All products are for laboratory research purposes only. Not for human consumption.
Synthetic GHRH(1-44) analogue, trans-3-hexenoyl modified
Tesamorelin
Tesamorelin is a synthetic 44-amino-acid analogue of human growth-hormone-releasing hormone, modified with an N-terminal trans-3-hexenoyl group that improves resistance to enzymatic degradation. Supplied as a lyophilised powder, boxed in tens, for laboratory research use only.
$160.71 (£126.96) per box of 10 vials · 10 mg, 20 mg
Overview
What is Tesamorelin?
Tesamorelin is a synthetic 44-amino-acid analogue of human growth-hormone-releasing hormone, modified with an N-terminal trans-3-hexenoyl group that improves resistance to enzymatic degradation. Supplied as a lyophilised powder, boxed in tens, for laboratory research use only.
Tesamorelin at a glance
| Compound | Tesamorelin |
|---|---|
| Also known as | TH9507, Tesamorelin acetate, GHRH(1-44) analogue |
| Classification | Synthetic GHRH(1-44) analogue, trans-3-hexenoyl modified |
| CAS number | 218949-48-5 |
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5135.9 g/mol |
| Sequence | 44-residue GHRH analogue with an N-terminal trans-3-hexenoyl group |
| Purity | 99%+ by HPLC |
| Physical form | Lyophilised powder |
| Available strengths | 10 mg, 20 mg |
| Box quantity | 10 vials |
| Price from | $16.07 per vial ($160.71 per box) |
| Research status | An approved prescription medicine in the US and Canada for one specific indication. Not approved in the UK. Prohibited in competitive sport under the WADA S2 category. |
| Documentation | Batch-specific COA (Janoshik or Freedom Diagnostic) |
Nominal specifications. The authoritative figures for any given box are those printed on its batch COA.
Pricing
How much does Tesamorelin cost?
Tesamorelin starts at $16.07 per vial (£12.70), sold in boxes of 10 at $160.71. One box is the smallest order and there is no trade account or minimum spend. Larger volumes are negotiable.
| Strength | Per vial | Box of 10 |
|---|---|---|
| 10 mg | $16.07 £12.70 | $160.71 £126.96 |
| 20 mg | $28.54 £22.55 | $285.42 £225.48 |
Handling
How should Tesamorelin be stored and reconstituted?
Full explanation of why each of these matters: peptide handling and storage reference.
Research Context
What is Tesamorelin researched for?
Below is a plain-English summary of what published research has investigated, and what it has found. These are descriptions of research activity and published results. They are not claims about what Tesamorelin does, and nothing here is a statement that it is safe or effective for any purpose.
Growth hormone axis stimulation
Tesamorelin is a full-length GHRH analogue, carrying the complete 44-residue signal rather than a fragment. The hexenoyl group on the N-terminus protects it from the enzyme that would otherwise clear it within minutes. 1
Visceral fat research
Its approved clinical use concerns reduction of excess visceral abdominal fat in a specific patient group, and the majority of the clinical literature sits there. 12
Comparative GHRH pharmacology
As the most complete GHRH analogue available, it serves as the reference point when studying shorter analogues such as CJC-1295 and Modified GRF 1-29.
References
- 1Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J Clin Endocrinol Metab (2010). PMID 20554713
- 2Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin. Clin Infect Dis (2012). PMID 22495074
Links open the record on PubMed or PubMed Central. These are citations to published research, not claims about this product.
Applications
Where Tesamorelin is used in the laboratory
- GHRH receptor pharmacology and agonist binding studies
- Lipid metabolism research in cell culture models
- Comparative stability studies against native GHRH(1-44)
- Analytical characterisation of N-terminally modified peptides
Verification
Does Tesamorelin come with a COA?
Yes — every box. Each batch of Tesamorelin is analysed by Janoshik Analytical or Freedom Diagnostic. The certificate confirms identity by mass spectrometry and purity by HPLC, and is tied to the batch number printed on the vial label. You can ask to see it before you order.
Example COA. You receive the certificate matching your own batch.
Questions
Tesamorelin questions, answered
How does Tesamorelin differ from native GHRH?
Tesamorelin retains the full 44-residue GHRH sequence but adds a trans-3-hexenoyl group at the N-terminus. Native GHRH is rapidly cleaved by dipeptidyl peptidase-4; the added group slows that degradation considerably while preserving receptor binding.
How much does Tesamorelin cost?
Tesamorelin starts at $16.07 per vial, sold in boxes of 10 vials at $160.71 per box (about £126.96). 2 strengths available: 10 mg, 20 mg. There is no minimum order.
What purity is your Tesamorelin?
All batches test at 99%+ purity. Every box ships with a batch-specific Certificate of Analysis from Janoshik Analytical or Freedom Diagnostic, confirming identity by mass spectrometry and purity by HPLC.
Is there a minimum order for Tesamorelin?
No. You can order a single box of 10 vials. There is no trade account, bulk commitment or minimum spend.
How is Tesamorelin shipped?
Tracked and in discreet, plain packaging, dispatched within 1–3 working days. Delivery estimates are UK 5–7 working days, EU 8–10, USA 5–8 and rest of world 10–12. Full detail is on the shipping page.
Catalog
